A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial
Clarke, Jeffrey M., Gu, Lin, Wang, Xiaofei F., Stinchcombe, Thomas E., Stevenson, Marvaretta M., Ramalingam, Sundhar, Shariff, Afreen, Garst, Jennifer, Nixon, Andrew B., Antonia, Scott J., Crawford, Jeffrey, Ready, Neal E.
Published in JTO clinical and research reports (01.06.2022)
Published in JTO clinical and research reports (01.06.2022)
Get full text
Journal Article
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
Hensing, Thomas A., Wang, Xiaofei, Stinchcombe, Thomas E., Gao, Junheng, Knopp, Michael V., Watson, Mark, Dudek, Arkadiusz Z., Graziano, Stephen L., Patel, Jyoti D., Faller, Bryan A., Dragnev, Konstantin H., Kozono, David, Vokes, Everett E.
Published in JTO clinical and research reports (01.08.2021)
Published in JTO clinical and research reports (01.08.2021)
Get full text
Journal Article